app.uptrends.ai Open in urlscan Pro
76.76.21.142  Public Scan

Form analysis
0 forms found in the DOM

Text Content

Trending

Dashboard



Settings



Log In

Sign Up


MOST POPULAR STOCKS IN ONLINE CHATTER

Based on overall mention volume across thousands of accredited news sources
throughout the globe.

Market Sentiment Today

Expressed in stock market news, past 5 days

Slightly Bullish

-6.00% more bearish

Compared to 30d ago

Market Today

SPY

$476.68

-0.24%

Neutral News

QQQ

$409.56

-0.20%

Neutral News

IWM

$193.23

-1.36%

Neutral News

Trending Topics

AAPL

FTEC: Apple Outlook A Headwind - A research firm has downgraded Apple's stock
due to concerns about the company's outlook. Google's Cookie Crumble: How A
Browser Update Could Reshape $600B Ad World - Google is facing potential changes
to its advertising business due to a browser update. Alibaba falls behind rivals
amid restructuring, FT reports - Alibaba is behind its rivals in terms of
restructuring, according to the Financial Times. Apple agrees to settle lawsuit
over iTunes gift card scam - Apple has agreed to settle a lawsuit over an iTunes
gift card scam.

AMZN

AI stocks are expected to grow in the next few years as artificial intelligence
becomes more integrated into society. However, some analysts are concerned about
a potential "trough of disillusionment" where the public's expectations for AI
do not match its reality. Despite this, many experts remain bullish on AI
stocks, especially those that are leading the digital revolution.

MSFT

Three nonfiction authors have sued Microsoft and OpenAI for copyright
infringement, claiming that the companies used excerpts from their books without
permission to train AI models. This follows a lawsuit from The New York Times
earlier this month alleging similar infringement. Microsoft has responded by
saying that it is phasing out the WordPad feature in its Windows 11 operating
system, which the authors say was one of the main sources of the infringement.
Meanwhile, Intel has teamed up with DigitalBridge Group to form a new generative
AI company. The new company will be focused on

Overall
My Interests

Sign in to view

Sign in to view your interests


My Watchlist

Sign in to view

Sign in to view your watchlist


# Rows

10

30 days

Columns
Most MentionedSurging MentionsMost BullishMost Bearish

#NameSectorPrice (30d%)Mentions (30d%)News SentimentAlerts1
$MSFTMicrosoft Corporation

Information Technology
$388.47
+4.79%


21,935
-0.73%


Very Bearish
9 alerts
2
$AAPLApple Inc.

Information Technology
$185.92
-5.90%


8,403
-0.48%


Bearish
12 alerts
3
$AMZNAmazon.com, Inc.

Consumer Discretionary
$154.62
+3.10%


7,566
-0.58%


Very Bullish
13 alerts
4
$TSLATesla, Inc.

Consumer Discretionary
$218.89
-13.65%


6,769
-0.52%


Bearish
10 alerts
5
$GOOGLAlphabet Inc.

Communication Services
$142.65
+7.58%


4,438
-0.53%


Very Bullish
14 alerts
6
$GOOGAlphabet Inc.

Communication Services
$144.24
+7.77%


4,338
-0.53%


Very Bullish
14 alerts
7
$INTCIntel Corporation

Information Technology
$47.12
+2.08%


3,118
-0.47%


Bullish
6 alerts
8
$METAMeta Platforms Inc.

Communication Services
$374.49
+11.81%


3,020
-0.66%


Very Bullish
11 alerts
9
$JPMJPMorgan Chase & Co.

Financials
$169.05
+2.31%


2,528
-0.56%


Bearish
7 alerts
10
$AMDAdvanced Micro Devices, Inc.

Information Technology
$146.56
+5.33%


2,318
-0.56%


Very Bullish
12 alerts


YOUR TOPICS AND ALERTS

Based on conversation trends relating to your watchlists and interest groups

RECENT ALERTS



$EXEL

NEWS SURGE
1/7/2024 at 01:00 AM

Exelixis is a company focused on developing new treatments for cancer. The
company has several new drugs in development, and expects to file IND
applications for three new drugs in 2024. The company also has a share
repurchase program in place, and has completed a $550 million share repurchase
in 2023. Exelixis will continue its discussions with the FDA on a potential
regulatory path forward for its drug cabozantinib in mCRPC.

Mentions34
Vs Avg+33
Overall: Volatility
$VKTX

SENTIMENT SPIKE
1/7/2024 at 01:00 AM

Viking Therapeutics (VKTX) is a clinical-stage biopharmaceutical company that
focuses on developing novel therapies for patients with metabolic and endocrine
disorders. Based on recent insider activity, it seems that insiders are selling
more of their shares than they were earlier this year. However, analysts still
rate the stock as a strong buy with a $34.00 average price target.

SentimentBearish
Rank Change23%
Overall: Bearish
$BROS

SENTIMENT SPIKE
1/7/2024 at 01:00 AM

Dutch Bros is a coffee chain based in Oregon that is known for its customer
friendliness, distinctive drinks, and fast growth. The company has seen a 33%
year-over-year increase in revenue, and it is aiming to expand to 4,000 total
shops. However, the company faces competition from other coffee chains and has a
hefty debt.

SentimentBullish
Rank Change+14%
Overall: Bullish
$UTHR

SENTIMENT SPIKE
1/7/2024 at 01:00 AM

United Therapeutics is a company that markets and sells commercial therapies to
treat pulmonary arterial hypertension and high-risk neuroblastoma. The company
has seen positive growth in recent years, with a net profit of $267.6 million in
the most recent quarter. However, corporate insider sentiment is negative on the
stock, with insiders selling more shares in recent months than earlier in the
year. The current analyst consensus on United Therapeutics is a Moderate Buy
with an average price target of $294.11.

SentimentBearish
Rank Change26%
Overall: Bearish
$ZBH

SENTIMENT SPIKE
1/7/2024 at 01:00 AM

Zimmer Biomet Holdings, Inc. is a global medical technology company that has
been impacted by Covid-19. The company's current President and CEO has steered
it through solid growth over the last decade and holds almost $100 million of
common shares and units. The three founders of the company own about $2 billion
in common shares.

SentimentBearish
Rank Change17%
Overall: Bearish
Log in to see your custom alerts and topics!

Log In

RECENT TOPICS




Antitrust Apple

Mentions
154
$AAPL

FTEC: Apple Outlook A Headwind - A research firm has downgraded Apple's stock
due to concerns about the company's outlook. Google's Cookie Crumble: How A
Browser Update Could Reshape $600B Ad World - Google is facing potential changes
to its advertising business due to a browser update. Alibaba falls behind rivals
amid restructuring, FT reports - Alibaba is behind its rivals in terms of
restructuring, according to the Financial Times. Apple agrees to settle lawsuit
over iTunes gift card scam - Apple has agreed to settle a lawsuit over an iTunes
gift card scam.

#Foxconn
#Google
#iPhone
#Department of Justice
#SEC

AI stocks 2024

Mentions
174
$AMZN

AI stocks are expected to grow in the next few years as artificial intelligence
becomes more integrated into society. However, some analysts are concerned about
a potential "trough of disillusionment" where the public's expectations for AI
do not match its reality. Despite this, many experts remain bullish on AI
stocks, especially those that are leading the digital revolution.

#Nvidia
#Nvidia
#Nvidia
#Buy Hand Over Fist

AI technology

Mentions
134
$MSFT

Three nonfiction authors have sued Microsoft and OpenAI for copyright
infringement, claiming that the companies used excerpts from their books without
permission to train AI models. This follows a lawsuit from The New York Times
earlier this month alleging similar infringement. Microsoft has responded by
saying that it is phasing out the WordPad feature in its Windows 11 operating
system, which the authors say was one of the main sources of the infringement.
Meanwhile, Intel has teamed up with DigitalBridge Group to form a new generative
AI company. The new company will be focused on

#DigitalBridge
#Microsoft
#Intel
#Reuters
#Dee Templeton

Nike earnings sales

Mentions
106
$NKE

Nike's stock price is down 10.7% after their Q2 2024 earnings call, during which
they gave a softer outlook than expected. This caused shares of competitor
Adidas, Puma, and JD Sports to slump as well. Nike is looking to cut $2 billion
in costs in order to 'streamline' their company.

#Dick
#NKE
#Dow
#Foot Locker
#NIKE

Stock Market Volatility

Mentions
138
$NDAQ$AAPL

The NASDAQ 100 closed in the positive in New York, while Wall Street had its
second lower finish. Asian shares extended the global sell-off, with the dollar
holding gains. The US National Debt soared past $34 trillion, and gold bull
Peter Schiff warned of a crisis before the end of the year. US chip stocks
tumbled after the strongest year since 2009.

#Asian
#US
#Reuters
#U.S.
#Dow
Log in to see your custom alerts and topics!

Log In


TRENDING TOPICS AND ALERTS

Based on overall conversation trends

RECENT ALERTS



$EXEL

NEWS SURGE
1/7/2024 at 01:00 AM

Exelixis is a company focused on developing new treatments for cancer. The
company has several new drugs in development, and expects to file IND
applications for three new drugs in 2024. The company also has a share
repurchase program in place, and has completed a $550 million share repurchase
in 2023. Exelixis will continue its discussions with the FDA on a potential
regulatory path forward for its drug cabozantinib in mCRPC.

Mentions34
Vs Avg+33
Overall: Volatility
$VKTX

SENTIMENT SPIKE
1/7/2024 at 01:00 AM

Viking Therapeutics (VKTX) is a clinical-stage biopharmaceutical company that
focuses on developing novel therapies for patients with metabolic and endocrine
disorders. Based on recent insider activity, it seems that insiders are selling
more of their shares than they were earlier this year. However, analysts still
rate the stock as a strong buy with a $34.00 average price target.

SentimentBearish
Rank Change23%
Overall: Bearish
$BROS

SENTIMENT SPIKE
1/7/2024 at 01:00 AM

Dutch Bros is a coffee chain based in Oregon that is known for its customer
friendliness, distinctive drinks, and fast growth. The company has seen a 33%
year-over-year increase in revenue, and it is aiming to expand to 4,000 total
shops. However, the company faces competition from other coffee chains and has a
hefty debt.

SentimentBullish
Rank Change+14%
Overall: Bullish
$UTHR

SENTIMENT SPIKE
1/7/2024 at 01:00 AM

United Therapeutics is a company that markets and sells commercial therapies to
treat pulmonary arterial hypertension and high-risk neuroblastoma. The company
has seen positive growth in recent years, with a net profit of $267.6 million in
the most recent quarter. However, corporate insider sentiment is negative on the
stock, with insiders selling more shares in recent months than earlier in the
year. The current analyst consensus on United Therapeutics is a Moderate Buy
with an average price target of $294.11.

SentimentBearish
Rank Change26%
Overall: Bearish
$ZBH

SENTIMENT SPIKE
1/7/2024 at 01:00 AM

Zimmer Biomet Holdings, Inc. is a global medical technology company that has
been impacted by Covid-19. The company's current President and CEO has steered
it through solid growth over the last decade and holds almost $100 million of
common shares and units. The three founders of the company own about $2 billion
in common shares.

SentimentBearish
Rank Change17%
Overall: Bearish

RECENT TOPICS




Antitrust Apple

Mentions
154
$AAPL

FTEC: Apple Outlook A Headwind - A research firm has downgraded Apple's stock
due to concerns about the company's outlook. Google's Cookie Crumble: How A
Browser Update Could Reshape $600B Ad World - Google is facing potential changes
to its advertising business due to a browser update. Alibaba falls behind rivals
amid restructuring, FT reports - Alibaba is behind its rivals in terms of
restructuring, according to the Financial Times. Apple agrees to settle lawsuit
over iTunes gift card scam - Apple has agreed to settle a lawsuit over an iTunes
gift card scam.

#Foxconn
#Google
#iPhone
#Department of Justice
#SEC

AI stocks 2024

Mentions
174
$AMZN

AI stocks are expected to grow in the next few years as artificial intelligence
becomes more integrated into society. However, some analysts are concerned about
a potential "trough of disillusionment" where the public's expectations for AI
do not match its reality. Despite this, many experts remain bullish on AI
stocks, especially those that are leading the digital revolution.

#Nvidia
#Nvidia
#Nvidia
#Buy Hand Over Fist

AI technology

Mentions
134
$MSFT

Three nonfiction authors have sued Microsoft and OpenAI for copyright
infringement, claiming that the companies used excerpts from their books without
permission to train AI models. This follows a lawsuit from The New York Times
earlier this month alleging similar infringement. Microsoft has responded by
saying that it is phasing out the WordPad feature in its Windows 11 operating
system, which the authors say was one of the main sources of the infringement.
Meanwhile, Intel has teamed up with DigitalBridge Group to form a new generative
AI company. The new company will be focused on

#DigitalBridge
#Microsoft
#Intel
#Reuters
#Dee Templeton

Nike earnings sales

Mentions
106
$NKE

Nike's stock price is down 10.7% after their Q2 2024 earnings call, during which
they gave a softer outlook than expected. This caused shares of competitor
Adidas, Puma, and JD Sports to slump as well. Nike is looking to cut $2 billion
in costs in order to 'streamline' their company.

#Dick
#NKE
#Dow
#Foot Locker
#NIKE

Stock Market Volatility

Mentions
138
$NDAQ$AAPL

The NASDAQ 100 closed in the positive in New York, while Wall Street had its
second lower finish. Asian shares extended the global sell-off, with the dollar
holding gains. The US National Debt soared past $34 trillion, and gold bull
Peter Schiff warned of a crisis before the end of the year. US chip stocks
tumbled after the strongest year since 2009.

#Asian
#US
#Reuters
#U.S.
#Dow